Melatonin in relation to the antioxidative defense and immune systems: Possible implications for cell and organ transplantation

Journal of Molecular Medicine

Volumn 77, Issue 1, 1999, Pages 36-39

  Reiter, Russel J ^a   Maestroni, Georges J M ^b  

^a UNIVERSITY OF TEXAS HEALTH SCIENCE CENTER AT SAN ANTONIO   (United States)

^b INSTITUTE OF PATHOLOGY   (Switzerland)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIOXIDANT; MELATONIN;

CELL TRANSPLANTATION; CIRCADIAN RHYTHM; CONFERENCE PAPER; IMMUNE SYSTEM; IMMUNITY; ORGAN TRANSPLANTATION; OXIDATIVE STRESS; PHOTOPERIODICITY; PINEAL BODY; REPRODUCTION; SEASONAL VARIATION;

EID: 0032970773     PISSN: 09462716     EISSN: None     Source Type: Journal    
DOI: 10.1007/s001090050297     Document Type: Conference Paper

References (43)

1. 1. Bartness TJ, Powers JB, Hastings MH, Bittman EL, Goldman BD (1993) The timed influsion paradigm for melatonin delivery: what has it taught us about the melatonin signal, its reception, and the photoperiodic control of seasonal responses? J Pineal Res 15:161-190
2. 2. Quay WB (1986) Pineal and biorhythms. Pineal Res Rev 4:183-197
3. 3. Maestroni GJM (1993) The immunoendocrine role of melatonin. J Pineal Res 14:1-10
4. 4. Nelson RJ, Damas GE, Klein SL, Kriegsfeld LJ. (1995) The influence of season, photoperiod, and pineal melatonin on immune function. J Pineal Res 19:149-165
5. 5. Reiter RJ, Melchiorri D, Sewerynek E, Poeggeler B, Barlow-Walden LR, Chuang JI, Ortiz GG, Acuña-Castroviejo D (1995) A review of the evidence supporting melatonin's role as an antioxidant. J Pineal Res 18:1-12
6. 6. Bertuglia S, Marchiafava PL, Colantuoni A (1996) Melatonin prevents ischemia reperfusion injury in hamster cheek pouch microcirculation. Cardiovasc Res 31:947-952
7. 7. Sewerynek E, Reiter RJ, Melchiorri D, Ortiz GG, Lewinski A (1996) Oxidative damage in the liver induced by ischemia-reperfusion: protection by melatonin. Hepato-Gastroenterology 43:898-905
8. 8. Solom RN, Maguire JA, Hancock WW (1993) Mechanism of a clinically relevant protocol to induce tolerance of cardiac allographs. Transplantation 56:1309-1314
9. 9. Slakey DP, Roza AM, Preper GM, Johnson CP, Adams MB (1993) Delayed cardiac allograft rejection due to combined cyclosporine and antioxidant therapy. Transplantation 56:1305-1309
10. 10. Qayumi AK, Godin DV, Jamieson WRE, Ko KM, Poostizadeh A (1993) Correlation of red cell antioxidant status and heart-lung function in swine pretreated will allpurinol (a model of heart-lung transplantation). Transplantation 56:37-43
11. 11. Wichmann MW, Zelleneger R, DeMaso CM, Ayala A, Chaudry IH (1996) Melatonin administration attenuates depressed immune functions after trama-hemorrhage. J Surg Res 63:256-262
12. 12. Cutler RG (1995) Oxidative stress: its potential relevance to human disease and longevity determinants. Age 18:91-96
13. 13. Jaeschke A (1995) Mechanism of oxidant stress-induced acute tissue injury. Proc Soc Exp Biol Med 209:104-111
14. 14. Halliwell B (1995) Antioxidant characterization: methodology and mechanism. Biochem Pharmacol 49:1341-1348
15. 15. Sies H, Stahl W (1995) Vitamins E and C, β-carotene, and other carotenoids as antioxidants. Am J Clin Nutr 62 [Suppl]: 13155-13215
16. 16. Niki E, Noguchi N, Tsuchihashi H, Gotoh N (1995) Interaction among vitamin C, vitamin E and β-carotene. Am J Clin Nutr 62 [Suppl]: 13225-13265
17. 17. Costa EJX, Lopes RH, Lamy-Freund MT (1995) Permeability of pure lipid bilayers to melatonin. J Pineal Res 19:123-126
18. 18. Shida CS, Castrucci AML, Lamy-Freund MI (1994) High melatonin solubility in aqueous medium. J Pineal Res 16:198-201
19. 19. Melchiorri D, Reiter RJ, Sewerynek E, Hara M, Chen LD, Nistico G (1996) Paraquat toxicity and oxidative damage: reduction by melatonin. Biochem Pharmacol 51:1095-1099
20. 20. Abe M, Reiter RJ, Orhii PB, Kara M, Poeggeler B (1994) Inhibitory effect of melatonin on cataract formation in newborn rats: evidence for an antioxidative role for melatonin. J Pineal Res 17:94-100
21. 21. Vijayalaxmi, Reiter RJ, Sewerynek E, Poeggeler B, Leal BZ, Meltz ML (1995) Marked reduction of radiation-induced micronuclei in human blood lymphocytes pretreated with melatonin. Rad Res 143:102-106
22. 22. Menendez-Pelaez A, Reiter RJ (1993) Distribution of melatonin in mammalian tissues: the relative importance of nuclear versus cytosolic localization. J Pineal Res 15:59-69
23. 23. Packer L, Witt EH, Tritschler HJ (1995) Alpha-lipoic acid as an antioxidant. Free Rad Biol Med 19:227-250
24. 24. Poeggeler B, Saarela S, Reiter RJ, Tan DX, Chen LD, Manchester LC, Barlow-Walden LR (1994) Melatonin - a highly potent endogenous radical scavenger and electron donor: new aspects of the oxidation chemistry of this indole assessed in vitro. Ann NY Acad Sci 738:419-420
25. 25. Pieri C, Marra M, Moroni F, Decchioni R, Marcheselli F (1994) Melatonin: a peroxyl radical scavenger more effective than vitamin E. Life Sci 55:PL271-PL276
26. 26. Reiter RJ (1996) Functional aspects of the pineal hormone melatonin in combating cell and tissue damage induced by free radicals. Eur J Endocrinol 134:412-420
27. 27. Ben-Nathan D, Maestroni GJM, Lustig S, Conti S (1995) Protective effects of melatonin in mice infected with encephalitis virus. Arch Virol 140:223-230
28. 28. Ellis LC (1996) Melatonin reduces mortality from Aleutian disease in mink (Mustela vison). J Pineal Res 21:214-217
29. 29. Ben-Nathan D, Maestroni GJM, Conti A (1997) The protective effect of melatonin in viral and bacterial infections. In: Maestroni GJM, Conti A, Reiter RJ (eds) Therapeutic potential of melatonin. Karger, Basel pp 72-80
30. 30. Sewerynek E, Melchiorri D, Reiter RJ, Ortiz GG, Lewinski A (1995) Lipopolysaccharide-induced hepatotoxicity is inhibited by the antioxidant melatonin. Eur J Pharmacol 293:327-334
31. 31. Sewerynek E, Ortiz GG, Reiter RJ, Pablos MI, Melchiorri D, Daniels WMU (1996) Lipopolysaccharide-induced DNA damage is greatly reduced in rats treated with the pineal hormone melatonin. Molec Cell Endocrinol 117:183-188
32. 32. Maestroni GJM (1996) Melatonin as a therapeutic agent in experimental endotoxic shock. J Pineal Res 20:84-89
33. 33. Maestroni GJM, Pierpaoli W (1981) Pharmacological control of the hormonally modulated immune response. In: Ader R (ed) Psychoneuroimmunology. Academic Press, New York, pp 405-425
34. 34. Caroleo MC, Frasca D, Nistico G, Doria G (1992) Melatonin as immunomodulator in immunodeficient mice. Immunopharmacology 23:81-89
35. 35. Angeli A, Gatti G, Sartori ML, Del Ponte D, Cerignola R (1988) Effect of exogenous melatonin on human natural killer cell activity. An approach to the immunomodulatory role of the pineal gland. In: Gupta D, Attanasio A, Reiter RJ (eds) The pineal gland and cancer. Brain Research Promotion, Tübingen, pp 145-157
36. 36. Conti A, Maestroni GJM (1995) The clinical neuroimmunotherapeutic role of melatonin in oncology. J Pineal Res 19: 103-110
37. 37. Di Stefano A, Paulesu L (1994) Inhibitory effect of melatonin on production of IFN gamma or TNF alpha in peripheral blood mononuclear cells of some blood donors. J Pineal Res 17: 164-169
38. 38. Calvo JR, Rafi-El-Idrissi M, Pozo D, Guerrero JM (1995) Immunomodulatory role of melatonin: specific binding sites in human and rodent lymphoid cells. J Pineal Res 18:119-126
39. 39. Maestroni GJM (1995) T-Helper-2 lymphocytes as a peripheral target of melatonin. J Pineal Res 18:84-89
40. 40. Maestroni GJM, Conti A, Lissoni P (1994) Colony-stimulating activity and hematopoietic rescue from cancer chemotherapy compounds are induced by melatonin via endogenous interleukin 4. Cancer Res 54: 4740-4743
41. 41. Roth KA, Lorenz RG, Unanue RA, Weaver CT (1989) Nonopiate active proenkephalin-derived peptides are secreted by T helper cells. FASEB J 3:2401-2407
42. 42. Kahan BD, Gholerial R (1994) Immunosuppressive agents. Surg Clin North Am 74:1029-1054
43. 43. Penn I (1994) Malignancy. Surg Clin North Am 74:1247-1257